RxDoctor Payments Data

Ann Hefter

Nurse Practitioner · Appleton, WINPI 1003584145

Payments from drug & device makers

$4,286in general payments, 2019–2025

Across 59 payments — averaging $72.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Actelion Pharmaceuticals US, Inc.$263
  • Novartis$187
  • Johnson & Johnson$130
  • Alnylam Pharmaceuticals Inc.$95
  • Amgen$70
  • plus $391 from 12 others

What the payments were for

  • Travel & lodging$2,16150%
  • Food & beverage$2,02447%
  • Education$1002%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,286 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$30,464
Medicare patients
188
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban225$228,074
EntrestoSacubitril/Valsartan73$86,302
JardianceEmpagliflozin112$77,538
XareltoRivaroxaban46$46,285
Repatha SureclickEvolocumab50$37,474
BrilintaTicagrelor50$30,242
FarxigaDapagliflozin Propanediol16$13,358
Metoprolol Succinate342$5,027
Amiodarone Hcl38$3,136
Atorvastatin Calcium222$2,916
Losartan Potassium161$2,112
Potassium Chloride100$1,957
Rosuvastatin Calcium88$1,766
Midodrine Hcl23$1,735
Furosemide231$1,341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$65$228,074225 claims
NovartisEntresto$187$86,30273 claims
Boehringer IngelheimJardiance$15$77,538112 claims
Johnson & JohnsonXarelto$130$46,28546 claims
AstraZenecaBrilinta, Farxiga$31$43,60066 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

Other nurse practitioner in Appleton

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →